Debt AdvisoryHealthcareSIGNED
bioAffinity Technologies Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement
Value
$4M
Target
bioAffinity Technologies, Inc.
WallachBeth Capital announced that bioAffinity Technologies, Inc. has completed an approximately $4 million registered direct financing of common stock and a concurrent private placement, priced at-the-market under Nasdaq rules.
✦ Meridian Analysis
This headline describes a financing event for bioAffinity Technologies, a biotechnology company. The approximately $4 million raised through a registered direct offering and private placement represents a debt advisory type of transaction, providing capital for the company.
The Meridian Weekly
The week's largest deals and the Iberian ones, every Monday. Free.